ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20.
Saved in:
| Title: | ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20. |
|---|---|
| Authors: | Locke, Kenneth W.1 (AUTHOR) klocke@halozyme.com, Maneval, Daniel C.1 (AUTHOR), LaBarre, Michael J.1 (AUTHOR) |
| Source: | Drug Delivery. Dec2019, Vol. 26 Issue 1, p98-106. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
